Is it Finally Time to Embrace GM Crops?
News Dec 02, 2009
John Bingham, , Nov. 26, 2009
The mass consultation exercise, set to last a year, is being viewed by opponents of GM foods as a fresh push to persuade the British public to embrace the controversial technology.
It comes against a background of calls from scientists, politicians and business for a rethink. They argue that humanity must make use of new genetically modified crop strains to combat a future world food crisis linked to global warming, a growing population and water shortages.
But sceptics say that not enough is known to rule out environmental or health dangers from what some refer to as "Frankenstein foods". The last time the public were consulted on the issue, opposition to the new technology was strong but the FSA says that rising food prices and fears for future supplies mean it is time to re-examine the issue.
A focus group survey published by the FSA ahead of the national consultation exercise has already angered environmentalists by suggesting that opponents of GM foods are more motivated by "emotion" than "reasoned" argument.
At present only one variety of GM maize has been approved for cultivation inside the European Union, although crops grown outside, such as in the US, can be sold here if they are labelled. In Britain the Department for Environment Food and Rural Affairs has given the go-ahead for a trial involving a new strain of potatoes but there are no plans to licence any more at present.
But is it now time to finally accept GM foods? Are sceptics just being alarmist or is there a genuine danger? Is it, an some manufacturers suggest, becoming impossible to keep GM ingredients out of the food chain?
Genetic Diversity Helps Protect Against DiseaseNews
Why do populations have genetic diversity when 'Survival of the Fittest' suggests that only one gene pool should thrive? It's a question that is hard to answer experimentally. A new study looking at evolutionary change in real time in tiny fungal parasites may provide a solution.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE